DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
EXEL
EXELIXIS INC
759 institutions still hold EXELIXIS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 30161Q104·Biological Products, (No Diagnostic Substances)·759 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
759 institutions reported EXEL in Q1 2026. BlackRock, Inc. leads at 18.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 38
739 more holders available. Log in →